"We are excited to expand our senior management team with the addition of Michael and Robert, who each bring uniquely relevant experience and market proven expertise to our team," stated Mr.
"At the same time, we believe Robert's 25 years of experience bringing innovative new products to market in the orthopedic device and related orthopedic biologics industries will be instrumental as we continue to develop and invest in new procedure-driven products, including the re-launch of our Plexur P(TM) Biocomposite for procedural specific applications accompanied by human clinical information," continued Mr.
Prior to his role as Chief Business Development Officer at Pipeline Biomedical, Mr. McCarthy served as the President and CEO of Endius Inc., a minimally invasive surgical spine device company. He has also served as the global Vice President of Sales and Marketing for Implex Corp., a reconstructive, spinal, trauma and sports medicine developer. Before Implex, Mr. McCarthy was a principal at Oxford Medical Inc., an independent sales distribution organization for the Johnson & Johnson orthopedic product portfolio. He began his career in the industry at Johnson & Johnson where he held a variety of corporate orthopedic sales and marketing positions. Mr. McCarthy holds a Bachelor of Science in Business Administration from
Mr. Cohen has spent the past 25 years in the medical technology industry with a focus on product development for orthopedic devices and related biologics. Prior to his role at Pipeline Biomedical, Mr. Cohen served as the President of Zimmer Spine, Inc., a spinal products company, where he was responsible for product development, marketing and sales. He also served as the General Manager/Vice President, Research and Development at Zimmer Trabecular Metal Technology, Inc., a company focused on orthopedic reconstructive prosthetic and spinal implant systems, bone replacements and musculoskeletal research. Before this, he served as Vice President, Research and Development at Implex Corp. Mr. Cohen earned a Master of Science in Engineering Management, a Master of Science in Mechanical Engineering and a Bachelor of Science in Mechanical Engineering all from the
Pipeline Biomedical Holdings, LLC is a medical products and technology development company. During 2008, Pipeline provided consulting services to Osteotech. Messrs. McCarthy and Cohen each holds equity investments in Pipeline.
About Osteotech
Osteotech, Inc., headquartered in
Certain statements made throughout this press release that are not historical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company's ability to develop and introduce new products, differences in anticipated and actual product and service introduction dates, the ultimate success of those products in the marketplace, the continued acceptance and growth of current products and services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of
SOURCE Osteotech, Inc.